Clinical Trials Browser

Phase 3 × lenvatinib × Endocrine × Clear all

NCT02966093 2022-01-26

A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China

Phase 3 Completed

EndocrineHead & Neck

Differentiated Thyroid Cancer (DTC)